Better response with conjugate vaccine than with polysaccaride vaccine 12 months after rituximab treatment in lymphoma patients

No abstract is available for this paper.

• Publication year

  2012

• Venue

  British Journal of Haematology

• Publication date

  2012-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.2011.08867.xPMID 21923649
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin’s Lymphoma Patients Treated with Rituximab-Containing Regimens

  2011cited by this paper
• Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases.

  2006cited by this paper
• Reactivation of hepatitis B virus with rituximab

  2005cited by this paper
• Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study

  2005cited by this paper
• Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.

  2004cited by this paper
• Risks of testosterone replacement therapy in ageing men

  2004cited by this paper
• Delayed‐onset neutropenia associated with rituximab therapy

  2003cited by this paper
• Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

  1998cited by this paper
• Long-lived plasma cells: a mechanism for maintaining persistent antibody production.

  1998cited by this paper
• A modified enzyme-linked immunosorbent assay for measuring type-specific anti-pneumococcal capsular polysaccharide antibodies.

  1993cited by this paper
• An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay.

  1990cited by this paper

• Vaccination of adult patients with hematological malignancies, patients with asplenia and patients with nocturnal paroxysmal hemoglobinuria — guidelines of PTHiT and the Infectious Diseases Working Group of PALG

  2025cites this paper
• Management of vaccinations in patients with non‐Hodgkin lymphoma

  2024cites this paper
• Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients

  2023cites this paper
• Immunodeficiency Secondary to Malignancies and Biologics

  2021cites this paper
• Szczepienia ochronne u dorosłych chorych na nowotwory hematologiczne oraz u chorych z asplenią – zalecenia PTHiT i sekcji do spraw zakażeń PALG

  2018cites this paper
• Vaccinations in patients with hematological malignancies.

  2016cites this paper
• Prophylactic immunoglobulin therapy in secondary immune deficiency – an expert opinion

  2016cites this paper
• Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases

  2015cites this paper
• Advances in the treatment of primary and secondary immune deficiences

  2013cites this paper
• Pharmacoeconomics of immunoglobulins and indications for their use

  2013cites this paper